60429-438 : Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release


NDC: 60429-438
Labeler: Golden State Medical Supply, Inc.
Product Type: Human Prescription Drug
Drug Name:  Propafenone Hydrochloride
Dosage Form: Oral Capsule, Extended Release
Application #: ANDA078540
Rev. Date: 


Appearance:


Markings: par;211
Shapes:  Capsule
Colors:  Red
Size (mm): 27
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 60429-438-60: 60 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (60429‑438‑60)

Active Ingredients:

  • Propafenone Hydrochloride

Dosage Strength:

  • 425 mg

Inactive Ingredients:

  • Alcohol
  • Anhydrous Lactose
  • Butyl Alcohol
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Fd&c Blue No. 2
  • Fd&c Red No. 40
  • Fd&c Yellow No. 6
  • Ferrosoferric Oxide
  • Gelatin
  • Magnesium Stearate
  • Povidones
  • Propylene Glycol
  • Shellac
  • Titanium Dioxide
  • Water
  • Ethylcelluloses

Pharmaceutical Classes:

  • Antiarrhythmic [EPC]

Related Products:

Based on records with the same trade name.
  • 60429-436 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 60429-437 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 60429-976 Propafenone Hydrochloride 225 1/1 Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 51407-477 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 51407-478 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 51407-479 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
  • 0378-1258 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-1259 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-1261 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0591-2285 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-2286 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-2287 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0603-5448 Propafenone Hydrochloride 150 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0603-5449 Propafenone Hydrochloride 225 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0603-5450 Propafenone Hydrochloride 300 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0615-7574 Propafenone Hydrochloride 150 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0832-0740 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Upsher-smith Laboratories, LLC
  • 0832-0741 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Upsher-smith Laboratories, LLC
  • 0832-0742 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Upsher-smith Laboratories, LLC
  • 16571-736 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Rising Pharma Holdings, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 60429-438 QR Code

< Prev: 60429-437Next: 60429-440 >

Related Discussions:

Propafenone HCl
## Has anyone else experienced a trembling/vibrating/buzzing sensation after taking this drug? If so, did you ever find ... 1 reply
Propafenone+V5124
Different code than previous rx...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.